UBS raised the firm’s price target on UnitedHealth (UNH) to $430 from $378 and keeps a Buy rating on the shares. UnitedHealth sounded more confident on the growth trajectory for 2027 and beyond, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth price target raised to $408 from $286 at RBC Capital
- UnitedHealth price target raised to $415 from $325 at Oppenheimer
- UnitedHealth price target raised to $410 from $390 at BofA
- UnitedHealth price target lowered to $417 from $423 at Piper Sandler
- Enrollees of ACA plans learn of hefty premium increases, WSJ reports